Scientists reveal missing yew tree enzymes needed to make a common cancer drug
Taxol is a widely used chemotherapy drug – it has been used to treat millions…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Mitochondrial ribosomal protein family in cancers: Mechanistic insights and therapeutic implications
This review is collaboratively prepared by Prof. Yingli Zhang (Hangzhou Institute of Medicine (HIM), Chinese…
Epigenetic drivers of liver cancer: unraveling mechanisms behind hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of…
A technology that detects breast cancer relapses up to 5 years in advance has been developed
Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de…
Researchers capture first signs of ovarian cancer risk
Little is known about what causes ovarian cancer, and there is no way to detect…
The role of fusion genes in cancer development and treatment
Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer…
Study provides new insights into the genetic complexity of cancer metastasis
When cancer spreads from a primary tumour to new sites throughout the body, it undergoes…
EHA 2025: Increasing the donor pool for haematopoietic stem cell transplantation
Blood cancer patients in the US who may have previously struggled to find a donor…
Botox mitigates debilitating dry mouth in prostate cancer patients receiving radiopharmaceutical therapy
A dual-protective approach using botulinum toxin (Botox) alongside an anti-nausea patch significantly reduces salivary gland…
Depression and inflammation: A bad combo for lung cancer patients
For the first time, researchers have found that lung cancer patients who have a combination…